Concepedia

Can M. Buldun

CM

Statistics

Publications

5

Citations

275

H-Index

5

Active since

2017

Affiliations

University of Oxford(Current)

Jenner Institute

Roche (Switzerland)

Roche Pharma AG (Germany)

Can M. Buldun is an author at University of Oxford specializing in protein engineering, biotechnology, and pharmacy.

ORCID

Publications per year

2017–2022

5

Publications

5

Dual Plug-and-Display Synthetic Assembly Using Orthogonal Reactive Proteins for Twin Antigen Immunization

Karl D. Brune, Can M. Buldun, Yuanyuan Li et al. · Bioconjugate Chemistry · 2017 · 104 citations · Full text

, , +17

SnoopLigase Catalyzes Peptide–Peptide Locking and Enables Solid-Phase Conjugate Isolation

Can M. Buldun, Jisoo X. Jean, M.R. Bedford et al. · Journal of the American Chemical Society · 2018 · 83 citations

, , +17

SnoopLigase peptide-peptide conjugation enables modular vaccine assembly

Anne‐Marie Andersson, Can M. Buldun, David J. Pattinson et al. · Scientific Reports · 2019 · 38 citations · Full text

, , +17

Format chain exchange (FORCE) for high-throughput generation of bispecific antibodies in combinatorial binder-format matrices

Stefan Dengl, Klaus Mayer, Felix Bormann et al. · Nature Communications · 2020 · 35 citations · Full text

, , +17

Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodies

Steffen Dickopf, Can M. Buldun, Vedran Vasic et al. · Biological Chemistry · 2022 · 15 citations · Full text

, , +17

1–5 of 5